Range Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-309
| Closed | -$220K | – | 201 |
|
|
2024
Q4 | $220K | Buy |
+309
| New | +$220K | 0.1% | 171 |
|
|
2024
Q3 | – | Sell |
-262
| Closed | -$275K | – | 160 |
|
|
2024
Q2 | $275K | Buy |
262
+24
| +10% | +$25.2K | 0.14% | 146 |
|
|
2024
Q1 | $229K | Buy |
+238
| New | +$229K | 0.12% | 156 |
|
|
2023
Q1 | – | Sell |
-287
| Closed | -$207K | – | 182 |
|
|
2022
Q4 | $207K | Buy |
+287
| New | +$207K | 0.14% | 159 |
|
|
2022
Q2 | – | Sell |
-369
| Closed | -$258K | – | 175 |
|
|
2022
Q1 | $258K | Sell |
369
-23
| -6% | -$16.1K | 0.16% | 145 |
|
|
2021
Q4 | $248K | Sell |
392
-29
| -7% | -$18.3K | 0.16% | 147 |
|
|
2021
Q3 | $255K | Buy |
421
+9
| +2% | +$5.45K | 0.18% | 139 |
|
|
2021
Q2 | $230K | Buy |
+412
| New | +$230K | 0.17% | 147 |
|